JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.
- Published in:
- Drugs, 2017, v. 77, n. 5, p. 521, doi. 10.1007/s40265-017-0701-9
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2017 AND VI 77 AND IP 5
Results: 9
1
2
Therapeutic Options in Refractory Diabetic Macular Oedema.
- Published in:
- Drugs, 2017, v. 77, n. 5, p. 481, doi. 10.1007/s40265-017-0704-6
- By:
- Publication type:
- Article
3
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain-Adipocyte Axis.
- Published in:
- Drugs, 2017, v. 77, n. 5, p. 493, doi. 10.1007/s40265-017-0706-4
- By:
- Publication type:
- Article
4
The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.
- Published in:
- Drugs, 2017, v. 77, n. 5, p. 547, doi. 10.1007/s40265-017-0712-6
- By:
- Publication type:
- Article
5
Rucaparib: First Global Approval.
- Published in:
- Drugs, 2017, v. 77, n. 5, p. 585, doi. 10.1007/s40265-017-0716-2
- By:
- Publication type:
- Article
6
Plecanatide: First Global Approval.
- Published in:
- Drugs, 2017, v. 77, n. 5, p. 593, doi. 10.1007/s40265-017-0718-0
- By:
- Publication type:
- Article
7
Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex): A Review in Multiple Sclerosis-Related Spasticity.
- Published in:
- Drugs, 2017, v. 77, n. 5, p. 563, doi. 10.1007/s40265-017-0720-6
- By:
- Publication type:
- Article
8
Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN): A Review in Diabetic Macular Edema.
- Published in:
- Drugs, 2017, v. 77, n. 5, p. 575, doi. 10.1007/s40265-017-0722-4
- By:
- Publication type:
- Article
9
Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience.
- Published in:
- Drugs, 2017, v. 77, n. 5, p. 505, doi. 10.1007/s40265-017-0689-1
- By:
- Publication type:
- Article